Given that many previous studies have reported some changes in the expression levels of ATG10 in CRC and documented its effect on tumor suppression and since UC has been shown to increase the risk of CRC (Desai et al., 2015), future studies are recommended to design a long‐term survey to follow up all UC patients and monitor changes in the levels of ATG10 or some other ATGs to identify potential prognostic markers for UC. This evidence concerns the gene ATG10 and neoplasm.